StockNews.com Initiates Coverage on Veradigm (NASDAQ:MDRX)

Analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the software maker’s stock.

Veradigm Stock Performance

NASDAQ MDRX opened at $9.23 on Wednesday. Veradigm has a 1 year low of $5.01 and a 1 year high of $13.69. The stock’s 50-day moving average price is $9.59 and its two-hundred day moving average price is $9.06.

Institutional Investors Weigh In On Veradigm

Several hedge funds have recently made changes to their positions in MDRX. Innealta Capital LLC acquired a new stake in Veradigm during the 2nd quarter valued at $38,000. Tyro Capital Management LLC acquired a new position in Veradigm during the first quarter valued at $9,055,000. Meadow Creek Wealth Advisors LLC acquired a new position in Veradigm during the first quarter valued at $83,000. Vanguard Group Inc. boosted its position in Veradigm by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after acquiring an additional 95,291 shares during the period. Finally, Wellington Management Group LLP boosted its position in Veradigm by 117.8% during the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after acquiring an additional 3,140,483 shares during the period.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.